BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
BriaCell Therapeutics Corp.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 9, 2026
$3.38−0.02 (-0.59%)
Close on Oct 19, 2026
- Market cap
- $24.51M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 16, 2025(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Aug 25, 2025 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Mar 12, 2025(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Jan 2, 2020 | 1-for-300 reverse | Earlier per-share figures multiplied by 300 |